Integrating novel therapies into the management of moderate-to-severe ulcerative colitis: challenges and opportunities

被引：2
|
作者：
Ma, Christopher [1 ]
Choi, May Y. [1 ]
机构：
[1] Mayo Clin, Dept Gastroenterol & Hepatol, Phoenix, AZ 85054 USA
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2022年 / 7卷 / 02期
关键词：
MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1016/S2468-1253(21)00432-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：110 / 112
页数：3
相关论文
共 50 条
  • [41] Unresolved challenges in acute severe ulcerative colitis
    Vuyyuru, Sudheer K.
    Jairath, Vipul
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2024, 43 (01) : 9 - 14
  • [42] Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis
    Ng, Alexander Clevewood
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (10) : 1774 - 1774
  • [43] Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experience
    Nuki, Yoichiro
    Esaki, Motohiro
    Asano, Kouichi
    Maehata, Yuji
    Umeno, Junji
    Moriyama, Tomohiko
    Nakamura, Shotaro
    Matsumoto, Takayuki
    Kitazono, Takanari
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (06) : 700 - 705
  • [44] Recent Advances in the Management of Acute Severe Ulcerative Colitis
    San, Elaine Ong Ming
    Sharif, Kassem
    Rosiou, Konstantina
    Rennie, Michael
    Selinger, Christian Philipp
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (23)
  • [45] Pharmacokinetics of Infliximab in Children with Moderate-to-Severe Ulcerative Colitis: Results from a Randomized, Multicenter, Open-label, Phase 3 Study
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Padgett, Lakshmi
    Blank, Marion
    Johanns, Jewel
    Griffiths, Anne
    Ford, Joyce
    Zhou, Honghui
    Guzzo, Cynthia
    Davis, Hugh M.
    Hyams, Jeffrey
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (13) : 2753 - 2762
  • [46] Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naive Patients With Moderate-to-Severe Ulcerative Colitis in China
    Zhou, Ting
    Sheng, Yanan
    Guan, Haijing
    Meng, Rui
    Wang, Zijing
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [47] Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
    Lasa, Juan S.
    Olivera, Pablo A.
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (02): : 161 - 170
  • [48] Effectiveness and safety of vedolizumab and infliximab in biologic-naïve patients with moderate-to-severe ulcerative colitis: A multicenter, retrospective cohort study
    Meng, Rui Ping
    Huang, Bao Bao
    Wei, Yan Ling
    Lyu, Lin
    Yang, Huan
    Liu, Cheng
    Zhou, Hong Li
    Liao, Xi Ping
    Zhou, Jian Yun
    Xie, Xia
    JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (04) : 230 - 237
  • [49] Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia
    Gil, Fabio
    Juliao-Banos, Fabian
    Amador, Luisa
    Castano, Natalia
    Reyes, Juan Manuel
    PHARMACOECONOMICS-OPEN, 2022, 6 (06) : 837 - 846
  • [50] Novel oral-targeted therapies for mucosal healing in ulcerative colitis
    Antonelli, Elisabetta
    Villanacci, Vincenzo
    Bassotti, Gabrio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (47) : 5322 - 5330
12345